Prot#AK002-016X: A Phase 3, Multicenter, Open-Label, Extension Study to Evaluate the Efficacy and Safety of AK002 in Patients That Were Previously Enrolled in AK002-016 or AK002-012 Studies and have Eosinophilic Gastritis and/or Eosinophilic Duodenitis (f

Project: Research project

Project Details

StatusActive
Effective start/end date7/12/217/12/24

Funding

  • Allakos, Inc. (Prot#AK002-016X)